Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging

Improving treatment outcomes in multidrug‐resistant tuberculosis (MDR‐TB) is partly hampered by inadequate effective antitubercular agents. Development of bedaquiline and delamanid has potentially changed the treatment landscape for MDR‐TB. This review provides an update on the progress of these nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Sun, Feng, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Overviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590425/
https://www.ncbi.nlm.nih.gov/pubmed/30548290
http://dx.doi.org/10.1002/ddr.21498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590425/
https://www.ncbi.nlm.nih.gov/pubmed/30548290
http://dx.doi.org/10.1002/ddr.21498

Ejemplares similares